Most cited papers from Tata Memorial Hospital

Tata Memorial Hospital

What are the most cited papers from Tata Memorial Hospital?

The most cited paper from Tata Memorial Hospital is "Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012" (Jacques Ferlay, Isabelle Soerjomataram, Rajesh Prabhakar Dikshit et al., 2014), with 29,250 citations. Next come "The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines" (5,605) and "The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After" (4,323).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 59 papers. Every paper with more than 476 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 Jacques Ferlay, Isabelle Soerjomataram, Rajesh Prabhakar Dikshit et al. · International Journal of Cancer Open access	13 Sep 2014	29,250
2	The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines Riaz Agha et al. · International Journal of Surgery Open access	9 Nov 2020	5,605
3	The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After Claudio Bassi et al. · Surgery Open access	28 Dec 2016	4,323
4	The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms Joseph David Khoury et al. · Leukemia Open access	22 Jun 2022	4,204
5	The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms Rita Alaggio et al. · Leukemia Open access	22 Jun 2022	4,010
6	The repertoire of mutational signatures in human cancer Ludmil B. Alexandrov et al. · Nature Open access1,384 authors	5 Feb 2020	3,854
7	Pan-cancer analysis of whole genomes Lauri A. Aaltonen et al. · Nature Open access1,324 authors	5 Feb 2020	3,360
8	Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 Christina Fitzmaurice et al. · JAMA Oncology Open access628 authors	27 Sep 2019	2,699
9	International network of cancer genome projects Jennifer L. Jennings et al. · Nature Open access256 authors	13 Apr 2010	2,439
10	The SCARE 2018 statement: Updating consensus Surgical CAse REport (SCARE) guidelines Riaz Agha et al. · International Journal of Surgery Open access	18 Oct 2018	2,340
11	STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery Ginimol Mathew et al. · International Journal of Surgery Open access	10 Nov 2021	2,166
12	Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 Jonathan Kocarnik et al. · JAMA Oncology Open access601 authors	30 Dec 2021	2,100
13	Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer) Nick Thatcher, Alex Y. Chang, Purvish Mahendra Parikh et al. · The Lancet	Oct 2005	2,097
14	Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial Christina Davies et al. · The Lancet Open access	5 Dec 2012	2,067
15	Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations Jason Phua, Li Weng, Lowell Ling et al. · The Lancet Respiratory Medicine Open access	6 Apr 2020	1,580
16	IHC Profiler: An Open Source Plugin for the Quantitative Evaluation and Automated Scoring of Immunohistochemistry Images of Human Tissue Samples Frency Varghese, Amirali B. Bukhari, Renu Malhotra et al. · PLoS ONE Open access	6 May 2014	1,383
17	Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial Edward B. Garon et al. · The Lancet Open access	2 Jun 2014	1,321
18	HPV Screening for Cervical Cancer in Rural India Rengaswamy Sankaranarayanan, Bhagwan M. Nene, Surendra Srinivas Shastri et al. · New England Journal of Medicine	Apr 2009	1,300
19	International Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy Donald E. Low et al. · Annals of Surgery	21 Jan 2015	1,162
20	Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma Anupama Reddy et al. · Cell Open access	Oct 2017	1,154
21	The evolutionary history of 2,658 cancers Moritz Gerstung et al. · Nature Open access1,441 authors	5 Feb 2020	1,149
22	Lung cancer immunotherapy: progress, pitfalls, and promises Aritraa Lahiri, Avik Maji, Pravin D. Potdar et al. · Molecular Cancer Open access	21 Feb 2023	1,095
23	Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ Alessandro Gronchi et al. · Annals of Oncology Open access	22 Jul 2021	1,057
24	Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial Roger Stupp et al. · The Lancet Oncology Open access	19 Aug 2014	1,053
25	Global burden of cancer attributable to high body-mass index in 2012: a population-based study Melina Arnold, Nirmala Pandeya, Graham B Byrnes et al. · The Lancet Oncology Open access	25 Nov 2014	1,017
26	Patterns of somatic structural variation in human cancer genomes Yilong Li et al. · Nature Open access1,411 authors	5 Feb 2020	1,005
27	Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Sibylle Loibl et al. · Annals of Oncology Open access	13 Dec 2023	991
28	Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS) Maximilian Bockhorn et al. · Surgery	7 Feb 2014	976
29	ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies Giacomo Grasselli et al. · Intensive Care Medicine Open access	16 Jun 2023	968
30	Suicide mortality in India: a nationally representative survey Vikram Patel, Chinthanie F. Ramasundarahettige, Lakshmi Vijayakumar et al. · The Lancet Open access	Jun 2012	947
31	The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies Richard Pötter et al. · Clinical and Translational Radiation Oncology Open access	11 Jan 2018	946
32	The PROCESS 2018 statement: Updating Consensus Preferred Reporting Of CasE Series in Surgery (PROCESS) guidelines Riaz Agha et al. · International Journal of Surgery Open access	22 Oct 2018	910
33	Benchmarking Complications Associated with Esophagectomy Donald E. Low et al. · Annals of Surgery Open access	5 Dec 2017	903
34	The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours Holger Moch, Mahul B. Amin, Daniel Maurice Berney et al. · European Urology Open access	16 Jul 2022	884
35	The PROCESS 2020 Guideline: Updating Consensus Preferred Reporting Of CasE Series in Surgery (PROCESS) Guidelines Riaz Agha et al. · International Journal of Surgery Open access	12 Nov 2020	800
36	The STROCSS statement: Strengthening the Reporting of Cohort Studies in Surgery Riaz Agha et al. · International Journal of Surgery Open access	8 Sep 2017	796
37	Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing Isidro Cortés-Ciriano et al. · Nature Genetics Open access1,407 authors	5 Feb 2020	793
38	Optimized Hydrophobic Interactions and Hydrogen Bonding at the Target-Ligand Interface Leads the Pathways of Drug-Designing Rohan Patil, Suranjana Das, Ashley Stanley et al. · PLoS ONE Open access	16 Aug 2010	766
39	The Lancet Commission on prostate cancer: planning for the surge in cases Nicholas David James et al. · The Lancet Open access	Apr 2024	723
40	Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study Alina Emiliana Sturdza et al. · Radiotherapy and Oncology	30 Apr 2016	712
41	Global cancer surgery: delivering safe, affordable, and timely cancer surgery Richard Sullivan et al. · The Lancet Oncology Open access	Sep 2015	709
42	Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: A consensus statement by the International Study Group on Pancreatic Surgery (ISGPS) Johanna A.M.G. Tol et al. · Surgery	22 Jul 2014	677
43	Analyses of non-coding somatic drivers in 2,658 cancer whole genomes Esther Rheinbay et al. · Nature Open access1,621 authors	5 Feb 2020	674
44	Common pitfalls in statistical analysis: Logistic regression Priya Ranganathan, Conjeevaram S. Pramesh, Rakesh Aggarwal · Perspectives in Clinical Research Open access	Jul 2017	670
45	Intubation Practices and Adverse Peri-intubation Events in Critically Ill Patients From 29 Countries Vincenzo Russotto et al. · JAMA Open access404 authors	23 Mar 2021	668
46	MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study Richard Pötter et al. · The Lancet Oncology Open access	29 Mar 2021	666
47	Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 Silke Gillessen et al. · European Urology Open access	24 Jun 2017	644
48	Guidelines for Perioperative Care in Esophagectomy: Enhanced Recovery After Surgery (ERAS ® ) Society Recommendations Donald E. Low, William Allum, Giovanni De Manzoni et al. · World Journal of Surgery	Oct 2018	638
49	Cancer survival in Africa, Asia, and Central America: a population-based study Rengaswamy Sankaranarayanan et al. · The Lancet Oncology	12 Dec 2009	632
50	Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo Giovanni Casali et al. · Annals of Oncology Open access	21 Sep 2021	608

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.